By comparing the proportional differences between recurrent and non-recurrent tumor cells, we found that CXCL13+ CD4+ and CD8+ T cell subsets were enriched in non-recurrent tumors (Figs. 2e, S4e). Here, CXCL13 is linked to neoplasm.